Enveric Biosciences (ENVB) EBITDA Margin Growth (1y) (2015 - 2020)
Enveric Biosciences (ENVB) EBITDA Margin Growth (1y) (2015 - 2020) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.40 Bn | 131.54 Bn | 2.84 Bn | -143.00 |
| 2 | Regeneron Pharmaceuticals | 86.13 Bn | 78.13 Bn | 3.93 Bn | 78.00 |
| 3 | Argenx Se | 65.58 Bn | 60.40 Bn | 1.37 Bn | 1,135.00 |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn | 7,666.00 |
| 5 | BeOne Medicines | 42.18 Bn | 37.08 Bn | 1.53 Bn | 1,238.00 |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn | 2,002.00 |
| 7 | BioNTech SE | 27.97 Bn | 9.58 Bn | 668.28 Mn | -3,558.00 |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 29,091.00 |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | -1,651.00 |
| 10 | Enveric Biosciences | 5.72 Mn | -2.57 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 1,133.00 |
| Jun 30, 2020 | 411.00 |
| Mar 31, 2020 | 344.00 |
| Dec 31, 2019 | 12,757.00 |
| Sep 30, 2019 | -7,479.00 |
| Jun 30, 2019 | -366.00 |
| Mar 31, 2019 | 20.00 |
| Dec 31, 2018 | -7,699.00 |
| Sep 30, 2018 | 8,917.00 |
| Jun 30, 2018 | 1,885.00 |
| Mar 31, 2018 | -725.00 |
| Dec 31, 2017 | -1,052.00 |
| Sep 30, 2017 | -1,865.00 |
| Jun 30, 2017 | -1,459.00 |
| Mar 31, 2017 | 888.00 |
| Dec 31, 2016 | 536.00 |
| Sep 30, 2016 | -577.00 |
| Jun 30, 2016 | -1,859.00 |
| Mar 31, 2016 | -3,912.00 |
| Jun 30, 2015 | -983.00 |